Webcast
Live Panel Discussion Replay: The Globalization of Clinical Trials - The Good, The Bad & The Overall Impact on Pharma Development
To view the media player you will need Adobe Flash!
Download Adobe Flash
Download Adobe Flash
The video player is loading...
The last decade has seen the proliferation of multinational clinical trials having sites in six or more countries, often spanning two or even three continents. The expansion of clinical trials to previously untapped locations has had many benefits:
- Improved ability to maintain strong recruitment rates
- Advanced capability to file/launch a new drug in many markets quickly
Along with the benefits, the shift to large multinational studies has also introduced difficulties:
- Study teams are faced with increased logistical and administrative challenges
- Technical infrastructure, time zones, multiple languages and remote locations of sites create new obstacles for data collection and communication.
In this panel discussion, pharmaceutical industry professionals currently working on global clinical trials speak to these topics as well as strategies they have employed to execute their multinational trials successfully.
More Webcasts
Whistleblowing, Bounty Hunting, and Retaliation: New Compliance Challenges for your Organization
This webcast will provide in house counsel, compliance professionals, and HR with an overview of:
- The latest whistleblower protection laws, including heightened FCPA enforcement and how the Dodd-Frank corporate whistleblower program is turning employees into bounty hunters.
- Anti-retaliation protections, including recent cases that have changed both the breadth and scope of retaliation claims.
- Practical strategies and best practices for organizations to mitigate skyrocketing whistleblower and retaliation risk.
On-Demand Video Webcast: Intellectual Property M&A
mergermarket, in association with IntraLinks, hosted the live webcast, Intellectual Property M&A. The webcast will discuss some the importance of Intellectual Property as a driver of M&A.
Podcast: Quarterly M&A Update
In this latest quarterly podcast, mergermarket and IntraLinks assembled a panel of transatlantic dealmakers to discuss what influenced M&A from April to September. After a bumper first half for global deal volumes, Q3 saw the market hit by a wave of uncertainty over sovereign debt and sluggish global economic growth. But what was our panel’s impression of the market?
IntraLinks for Alternative Investment Fund Administrators: Collaborating to Increase the Top and Bottom Lines
Discover how IntraLinks can help Fund Administrators capitalize on emerging opportunities while controlling their costs. The presentation will walk you through the IntraLinks solutions and capabilities Fund Administrators are leveraging to expand their service suite, engage earlier with prospects and attract large self administered funds that are moving to 3rd party administration.
Strengthening Sponsor/CRO and Clinical Research Site Connections
Understand how the use of extended enterprise collaboration technologies is helping the clinical research community gain operational efficiencies and strengthen relationships between clinical research sites and Sponsors/CROs. Hear firsthand how clinical research sites interact, correspond, collaborate and share information with Sponsor Organizations, and their perceived challenges with their current methods.